Generic Name and Formulations:
Anthralin 1%; crm, contains salicylic and ascorbic acid.
Indications for DRITHO-CREME:
Quiescent or chronic psoriasis.
Initially apply once daily (5–10 minutes contact time) for at least one week; may increase contact time to 20–30 minutes before washing off. Treat until skin is entirely clear. Individualize. For skin: use sparingly. For scalp: wash and rinse hair.
Acute psoriatic eruptions.
Renal disease. Avoid eyes, mucous membranes, folds and creases of the skin. Apply cautiously on intertriginous skin areas. Restrict application to psoriatic lesions. Discontinue if sensitization or excessive irritation develops. May stain fabrics; avoid. Pregnancy (Cat.C). Nursing mothers.
Possible contact allergic reactions, severe irritation, discolored hair or fingernails.
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis